Cancer Science Market Analysis and Reports | Portugal Conference Series

Market Analysis - Cancer Science 2017

Summary

Cancer is the second leading cause of death worldwide and in all regions of the world. It has undergone a period of dramatic economic, social, and demographic change, resulting in increased life expectancy and prosperity. Cancer is when abnormal cells divide in an uncontrolled way. Some cancers may eventually spread into other tissues. There are more than 200 different types of cancer.

Importance & Scope

It’s crucial to remember that cancer is not one disease – it’s more than 200 cancer diseases involved. All different, unique diseases, which require different approaches for treatment. Treatments that work for some cancers don’t work for others and sometimes those treatments simply stop working. Only worldwide research will enhance our understanding of cancer and help us find and develop better, more effective treatments. And only a global search for answers will help us get to grips with this disease. . The conference will provide with an exceptional opportunity for the delegates from Universities and Institutes to interact with the world class Scientists and Industry Professionals working in the field of cancer/oncology. The conference will provide with an exceptional opportunity for the delegates from Universities and Institutes to interact with the world class Scientists and Industry Professionals working in the field of cancer/oncology.

Cancer Science 2017 will also explore the new ideas and concepts on global scale and the topics Cancer Science & Therapy, Cancer Cell Biology, Organ-Defined Cancers, Tumour Science, Cancer Genetics, Clinical Cancer Research, Cancer & Tumour Immunology, Cancer : Genomics & Metabolomics, Targeted Cancer Therapy, Stem Cell Therapy, Cancer Biomarkers, Cancer Treatment & Therapeutics, Cancer Clinical Trials, Cancer Case Reports, Cancer Drug Diagnostics & Therapeutics, Frontiers in Cancer Science, Precision Medicine & Cancer Therapy, Cancer Management & Prevention, Economic Impact of Cancer Therapy.

For More details please visit: http://cancerscience.conferenceseries.com/

Why Lisbon?

Lisbon is the continental Europe's westernmost capital city. A leading Cancer Center in Portugal became the first in world to Edge™ Radiosurgery. Lisbon and its heavily populated surroundings are also developing as an important financial centre and a dynamic technological hub. It is also s recognised as a global city because of its importance in finance, commerce, media, entertainment, arts, international trade, education and tourism. Due to the advancements in the field of cancer research in Lisbon, it is been seen as the apt destination for the conference.

Brief Report of Market on Cancer Research

There are recent advancements in the cancer treatments & cancer care is accelerating. A cluster of innovative treatments, often combined with other new or existing medicines, and frequently associated with biomarkers, are emerging from the research and development pipeline.Over the past five years, 70 new oncology treatments have been launched and are being used to treat over 20 different tumour types.

The global cancer immunotherapies market reached $30.8 billion in 2012. This market is expected to grow to nearly $34.3 billion in 2013 and $67.9 billion in 2018 with a compound annual growth rate (CAGR) of 14.7% over the five-year period, 2013 to 2018. This report   includes discussion of the regulatory environment, current and developing technologies, cancer incidence, market projections and market share, along with latest trends and clinical trials.

Figure 1: Global Cancer Immunotherapies Market (2012-2018)

      

The total cost of cancer therapeutics and medicines used in supportive care– measured at the ex-manufacturer price level before the application of rebates or other price concessions – reached $107 billion in 2015, representing an increase in constant dollars of 11.5% over the prior year

Annual global growth in the oncology drug market is expected to be 7.5 – 10.5 % through 2020, reaching $150 billion. Wider utilization of new products—especially immunotherapies—will drive much of the growth, offset by reduced use of some existing treatments with inferior clinical outcomes.

The global market for biologic cancer treatment totalled about $51.2 billion in 2014 and is expected to reach $66.4 billion in 2019, registering a compound annual growth rate (CAGR) of 5.4% for the period 2014-2019. It includes current issues and trends affecting the industry, costs and factors influencing demand. The report covers biological products in development, biological products in clinical trials, and currently marketed and late-stage development biologic cancer products.

Figure 2: Global Market for Biologic Cancer Treatment(2014-2019)

         

Summary

Cancer is the second leading cause of death worldwide and in all regions of the world. It has undergone a period of dramatic economic, social, and demographic change, resulting in increased life expectancy and prosperity. Cancer is when abnormal cells divide in an uncontrolled way. Some cancers may eventually spread into other tissues. There are more than 200 different types of cancer.

Importance & Scope

It’s crucial to remember that cancer is not one disease – it’s more than 200 cancer diseases involved. All different, unique diseases, which require different approaches for treatment. Treatments that work for some cancers don’t work for others and sometimes those treatments simply stop working. Only worldwide research will enhance our understanding of cancer and help us find and develop better, more effective treatments. And only a global search for answers will help us get to grips with this disease. . The conference will provide with an exceptional opportunity for the delegates from Universities and Institutes to interact with the world class Scientists and Industry Professionals working in the field of cancer/oncology. The conference will provide with an exceptional opportunity for the delegates from Universities and Institutes to interact with the world class Scientists and Industry Professionals working in the field of cancer/oncology.

Cancer Science 2017 will also explore the new ideas and concepts on global scale and the topics Cancer Science & Therapy, Cancer Cell Biology, Organ-Defined Cancers, Tumour Science, Cancer Genetics, Clinical Cancer Research, Cancer & Tumour Immunology, Cancer : Genomics & Metabolomics, Targeted Cancer Therapy, Stem Cell Therapy, Cancer Biomarkers, Cancer Treatment & Therapeutics, Cancer Clinical Trials, Cancer Case Reports, Cancer Drug Diagnostics & Therapeutics, Frontiers in Cancer Science, Precision Medicine & Cancer Therapy, Cancer Management & Prevention, Economic Impact of Cancer Therapy.

For More details please visit: http://cancerscience.conferenceseries.com/

Why Lisbon?

Lisbon is the continental Europe's westernmost capital city. A leading Cancer Center in Portugal became the first in world to Edge™ Radiosurgery. Lisbon and its heavily populated surroundings are also developing as an important financial centre and a dynamic technological hub. It is also s recognised as a global city because of its importance in finance, commerce, media, entertainment, arts, international trade, education and tourism. Due to the advancements in the field of cancer research in Lisbon, it is been seen as the apt destination for the conference.